
via Universitat Rovira i Virgili
A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and non-invasively
Researchers at the URV’s Department of Physical and Inorganic Chemistry, led by the ICREA researcher, Ramon Álvarez Puebla, and the professor of Applied Physics, Francesc Díaz, and the Department of Clinical Oncology of the HM Torrelodones University Hospital, have patented a portable device that can detect tumour cells in blood.
The device counts the number of tumour cells in a blood sample in real time and is thus a highly effective tool for improving the monitoring, treatment and diagnosis of cancer.
Very useful for clinical use
The system has been successfully tested on patients in various stages of breast cancer and could be used to determine the presence of other tumours by analysing different antibodies in the blood sample.
Patients with cancer, particularly if it has metastasised, need to be constantly monitored during treatment to assess the progress of the disease. This is currently done using imaging techniques and biopsies which are invasive and not always possible. In contrast, the device designed by the URV researchers is highly sensitive and requires no surgery or treatment involving radiation. It is thus a highly useful clinical method because it improves patient quality of life by removing the need for the more invasive traditional procedures.
The device will be a useful tool for accurately determining a patient’s level of health because it can monitor cancer quickly, cheaply, effectively and non-invasively. Furthermore, it can assist in the early diagnosis of the disease and monitor tumours more effectively and in a manner that has a less negative effect on patients’ bodies.
Two integrated systems
The new device uses two systems in miniature: a flow system and an optical system. The first causes the blood cells to flow in alignment, while the second uses two optic fibres (a laser diode and a photodetector) to analyse the cells and count those which are cancerous and those which are not. The ratio between the two gives an understanding as to how the cancer is progressing.

Learn more: Researchers develop a device that detects tumour cells in blood
The Latest on: Cancer detection
-
Noah's Ark Preschool raises money for mom with breast cancer
on April 19, 2018 at 12:21 am
When Kim Masters, director of Noah’s Ark, found out about Austin’s diagnosis, she thought back to her own breast cancer diagnosis 10 years ago. Masters felt a familiar tug in her heart, and after talking with the preschool’s leadership team ... […]
-
BRIEF-Epigenomics: Blood Test Shows Promise In The Detection Of Liver Cancer
on April 18, 2018 at 10:05 pm
* RESULTS FROM TWO CLINICAL STUDIES DEMONSTRATE HIGH SENSITIVITY AND SPECIFICITY OF MSEPT9 BLOOD TEST Source text for Eikon: Further company coverage: (Gdynia Newsroom) Our Standards:The Thomson Reuters Trust Principles. […]
-
The holy 'Grail' of cancer: Early detection of tumors
on April 18, 2018 at 10:01 pm
CHICAGO – Attendees of the American Association for Cancer Research that stayed toward the end of the last full day of the meeting were handsomely rewarded with initial data from Grail Inc., which is still enrolling patients in its 15,000-participant ... […]
-
Surgical techniques emphasize conservation during treatment for breast cancer
on April 18, 2018 at 10:00 pm
Though treatment for breast cancer has changed, patients still often associate a diagnosis of breast cancer with disfiguring surgery. The original treatment for breast cancer was most commonly a mastectomy involving the entire chest wall. Today ... […]
-
Nanodisc-delivered cancer treatment helps eliminate tumors
on April 18, 2018 at 8:43 pm
But some cancer cells avoid an immune system attack by producing proteins ... we saw better accumulation of the drug in the tumor and we didn't detect any cardiotoxicity," Schwendeman says. "HDL is known to have benefits for the heart. […]
-
‘Squeezing’ cells can more accurately diagnose breast cancer, UC Berkeley study says
on April 18, 2018 at 7:52 pm
The study, which was done in collaboration with the City of Hope National Medical Center, introduced mechano-NPS as a technique that can help detect cancer earlier and with more accuracy than other techniques currently available. “Because we’re so ... […]
-
Abby Lee Miller Receives Initial Diagnosis of Non-Hodgkin's Lymphoma
on April 18, 2018 at 6:47 pm
One day after undergoing emergency spinal surgery for what was believed to be an infection in her spine, reality star Abby Lee Miller has now been preliminary diagnosed with Burkitt lymphoma, a form of non-Hodgkin's lymphoma, a cancer of the lymph nodes ... […]
-
Polypharmacy more likely for cancer survivors
on April 18, 2018 at 11:40 am
a higher percentage of cancer survivors were prescribed five or more unique medications (64 versus 51.5 percent), including drugs with abuse potential. Compared with controls, a higher percentage of newly (one year or less since diagnosis) and previously ... […]
-
Researchers identify link between physical inactivity and increased risk of dying from cancer
on April 18, 2018 at 10:54 am
The investigators looked at patterns of physical activity over time, during a period spanning the decade before the cancer was diagnosed and continuing for up to one year after diagnosis. Cancer patients who engaged in regular, moderate- to vigorous ... […]
-
Biosensors for bladder cancer diagnosis
on April 17, 2018 at 6:31 am
Cancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sensitive diagnostics capable of detecting cancer-related molecules are necessary. Despite technological ... […]
via Google News and Bing News